QUEST DIAGNOSTICS INC (DGX) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, QUEST DIAGNOSTICS INC's filing signal turned positive.

Quest Diagnostics is a leading provider of diagnostic information services, serving approximately one-third of the U.S. adult population annually. The company offers a comprehensive menu of routine, non-routine, and advanced clinical testing and anatomic pathology services, leveraging a vast database of de-identified clinical lab results. Quest Diagnostics partners with physicians, hospitals, patients, health plans, and employers, providing insights to improve health outcomes and manage costs. Its strategy focuses on growth through innovation, strategic acquisitions, and operational efficiency, supported by advanced diagnostics in areas like oncology and neurology. The company operates an extensive network of laboratories and patient service centers across the United States and internationally, including its recent acquisition of LifeLabs in Canada.

Revenue is primarily driven by the volume of test requisitions and the revenue per requisition, influenced by test mix, payer mix, and business mix. The company also generates revenue from its risk assessment services and healthcare IT businesses.